Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 330

1.

Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis.

Pavasini R, d'Ascenzo F, Campo G, Biscaglia S, Ferri A, Contoli M, Papi A, Ceconi C, Ferrari R.

Int J Cardiol. 2015 Jul 15;191:187-93. doi: 10.1016/j.ijcard.2015.05.006. Epub 2015 May 6.

PMID:
25965630
2.

Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study.

Campo G, Pavasini R, Biscaglia S, Ferri A, Andrenacci E, Tebaldi M, Ferrari R.

Pharmacol Res. 2015 Jul;97:1-6. doi: 10.1016/j.phrs.2015.03.020. Epub 2015 Apr 3.

PMID:
25846253
3.

Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.

Biscaglia S, Ferri A, Pavasini R, Campo G, Ferrari R.

J Atheroscler Thromb. 2015 May 20;22(5):535-41. doi: 10.5551/jat.29371. Epub 2015 Apr 3.

4.

Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD.

Campo G, Pavasini R, Malagù M, Punzetti S, Napoli N, Guerzoni F, Papi A, Ceconi C, Contoli M.

COPD. 2015 Mar 16. [Epub ahead of print]

PMID:
25775224
5.

Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.

Valgimigli M, Patialiakas A, Thury A, McFadden E, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Airoldi F, Ferlini M, Liistro F, Dellavalle A, Vranckx P, Briguori C; ZEUS Investigators.

J Am Coll Cardiol. 2015 Mar 3;65(8):805-15. doi: 10.1016/j.jacc.2014.11.053.

PMID:
25720624
6.

Scale effect of anaerobic digestion tests in fed-batch and semi-continuous mode for the technical and economic feasibility of a full scale digester.

Ruffino B, Fiore S, Roati C, Campo G, Novarino D, Zanetti M.

Bioresour Technol. 2015 Apr;182:302-13. doi: 10.1016/j.biortech.2015.02.021. Epub 2015 Feb 13.

PMID:
25710569
7.

Beta-arrestin 1 is involved in the catabolic response stimulated by hyaluronan degradation in mouse chondrocytes.

Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Calatroni A, Campo S.

Cell Tissue Res. 2015 Feb 13. [Epub ahead of print]

PMID:
25673209
8.

Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management.

Campo G, Pavasini R, Malagù M, Mascetti S, Biscaglia S, Ceconi C, Papi A, Contoli M.

Cardiovasc Drugs Ther. 2015 Apr;29(2):147-57. doi: 10.1007/s10557-014-6569-y.

PMID:
25645653
9.

Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system.

Biscaglia S, Secco GG, Tumscitz C, Di Mario C, Campo G.

Int J Cardiol. 2015 Mar 1;182:1-3. doi: 10.1016/j.ijcard.2014.12.103. Epub 2014 Dec 28. No abstract available.

PMID:
25590956
10.

Trends in incidence of occupational asthma, contact dermatitis, noise-induced hearing loss, carpal tunnel syndrome and upper limb musculoskeletal disorders in European countries from 2000 to 2012.

Stocks SJ, McNamee R, van der Molen HF, Paris C, Urban P, Campo G, Sauni R, Martínez Jarreta B, Valenty M, Godderis L, Miedinger D, Jacquetin P, Gravseth HM, Bonneterre V, Telle-Lamberton M, Bensefa-Colas L, Faye S, Mylle G, Wannag A, Samant Y, Pal T, Scholz-Odermatt S, Papale A, Schouteden M, Colosio C, Mattioli S, Agius R; Working Group 2; Cost Action IS1002—Monitoring trends in Occupational Diseases and tracing new and Emerging Risks in a NETwork (MODERNET).

Occup Environ Med. 2015 Apr;72(4):294-303. doi: 10.1136/oemed-2014-102534. Epub 2015 Jan 9.

PMID:
25575531
11.

[MALPROF and the Plan for Prevention].

Di Leone G, Campo G, Martini B.

G Ital Med Lav Ergon. 2014 Oct-Dec;36(4):357-9. Review. Spanish.

PMID:
25558734
12.

Inhibition of small HA fragment activity and stimulation of A2A adenosine receptor pathway limit apoptosis and reduce cartilage damage in experimental arthritis.

Campo GM, Micali A, Avenoso A, D'Ascola A, Scuruchi M, Pisani A, Bruschetta A, Calatroni A, Puzzolo D, Campo S.

Histochem Cell Biol. 2015 May;143(5):531-43. doi: 10.1007/s00418-014-1298-7. Epub 2014 Dec 16.

PMID:
25511416
13.

Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results.

Nicolini F, Contini GA, Fortuna D, Pacini D, Gabbieri D, Vignali L, Campo G, Manari A, Zussa C, Guastaroba P, De Palma R, Gherli T.

Ann Thorac Surg. 2015 Feb;99(2):567-74. doi: 10.1016/j.athoracsur.2014.09.019. Epub 2014 Dec 10.

PMID:
25499479
14.

Improvement of anaerobic digestion of sewage sludge in a wastewater treatment plant by means of mechanical and thermal pre-treatments: Performance, energy and economical assessment.

Ruffino B, Campo G, Genon G, Lorenzi E, Novarino D, Scibilia G, Zanetti M.

Bioresour Technol. 2014 Oct 22;175C:298-308. doi: 10.1016/j.biortech.2014.10.071. [Epub ahead of print]

PMID:
25459836
15.

Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation.

Campo G, Lunghi B, Pavasini R, Ferraresi P, Punzetti S, Malagù M, Biscaglia S, Ferrari R, Bernardi F.

Int J Cardiol. 2014 Dec 15;177(2):711-3. No abstract available.

PMID:
25456690
16.

Inhibition of the hyaluronan oligosaccharides inflammatory response: reduction of adenosine 2A receptor activation by EPAC and PKA.

Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Nastasi G, Calatroni A, Campo S.

Cell Biochem Funct. 2014 Dec;32(8):692-701. doi: 10.1002/cbf.3073. Epub 2014 Nov 4.

PMID:
25367782
17.

Beta-arrestin-2 negatively modulates inflammation response in mouse chondrocytes induced by 4-mer hyaluronan oligosaccharide.

Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Calatroni A, Campo S.

Mol Cell Biochem. 2015 Jan;399(1-2):201-8. doi: 10.1007/s11010-014-2246-5. Epub 2014 Oct 16.

PMID:
25318610
18.

Fractional flow reserve-guided PCI for stable coronary artery disease.

De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E, Jüni P; FAME 2 Trial Investigators.

N Engl J Med. 2014 Sep 25;371(13):1208-17. doi: 10.1056/NEJMoa1408758. Epub 2014 Sep 1. Erratum in: N Engl J Med. 2014 Oct 9;371(15):1465.

19.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].

20.

Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury.

Morciano G, Giorgi C, Bonora M, Punzetti S, Pavasini R, Wieckowski MR, Campo G, Pinton P.

J Mol Cell Cardiol. 2015 Jan;78:142-53. doi: 10.1016/j.yjmcc.2014.08.015. Epub 2014 Aug 27.

PMID:
25172387
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk